These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8392012

  • 21. [Surgical treatment of hepatocarcinoma in cirrhosis].
    Launois B, Chauvin J, Machado ML, Bourdonnec P, Campion JP, Bardaxoglou E.
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):35-9; discussion 39-40. PubMed ID: 8669806
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis after transplantation.
    Ye MQ, Thung SN.
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S68-72. PubMed ID: 9742496
    [No Abstract] [Full Text] [Related]

  • 23. Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issues.
    Sotiropoulos GC, Beckebaum S, Lang H, Frilling A, Molmenti EP, Cicinnati VR, Saner FH, Erim Y, Baba HA, Malagó M, Broelsch CE.
    Eur Surg Res; 2008 Sep; 40(1):7-13. PubMed ID: 17717419
    [Abstract] [Full Text] [Related]

  • 24. Living donor liver transplantation for hepatitis C related hepatocellular carcinoma in a haemophilia A patient.
    Au WY, Liu CL, Lo CM, Fan ST, Lam CK.
    Haemophilia; 2005 Jul; 11(4):405-7. PubMed ID: 16011595
    [Abstract] [Full Text] [Related]

  • 25. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodríguez-Canete A, Gonzalez-Sanchez A.
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [Abstract] [Full Text] [Related]

  • 26. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S, Mason A, Eason J, Loss G, Perrillo RP.
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [Abstract] [Full Text] [Related]

  • 27. [Liver transplantation in Germany].
    Wolff M, Kalff JC, Schwarz NT, Lauschke H, Minor T, Tolba RH, Hirner A.
    Zentralbl Chir; 2003 Oct; 128(10):831-41. PubMed ID: 14628232
    [Abstract] [Full Text] [Related]

  • 28. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M, Neuberger JM, Gunson BK, Hübscher SG.
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [Abstract] [Full Text] [Related]

  • 29. Atrial fibrillation during veno-venous bypass for orthotopic liver transplantation.
    Chung M, Muntyan I.
    J Clin Anesth; 2011 Aug; 23(5):428-9. PubMed ID: 21680166
    [No Abstract] [Full Text] [Related]

  • 30. De novo autoimmune hepatitis following liver transplantation: a case report.
    Di Cocco P, Barletta A, Clemente K, D'Angelo M, Greco S, Mazzotta C, Orlando G, Rizza V, Famulari A, Grimaldi A, Pisani F.
    Transplant Proc; 2008 Aug; 40(6):2073-4. PubMed ID: 18675134
    [Abstract] [Full Text] [Related]

  • 31. Cardiac hemodynamic profiles and pro-B-type natriuretic Peptide in cirrhotic patients undergoing liver transplantation.
    Bernal V, Pascual I, Esquivias P, García-Gil A, Fernández C, Mateo JM, González M, Simón MA.
    Transplant Proc; 2009 Apr; 41(3):985-6. PubMed ID: 19376404
    [Abstract] [Full Text] [Related]

  • 32. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T.
    Anticancer Res; 2001 Apr; 21(4B):2937-40. PubMed ID: 11712790
    [Abstract] [Full Text] [Related]

  • 33. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters.
    Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, Langrehr J, Neuhaus P.
    Transplant Proc; 2005 May; 37(4):1693-4. PubMed ID: 15919433
    [Abstract] [Full Text] [Related]

  • 34. [Indications and results of liver transplantation in the treatment of hepatocellular carcinoma in cirrhosis].
    Adam R, Castaing D, Azoulay D, Majno P, Samuel D, Bismuth H.
    Ann Chir; 1998 May; 52(6):547-57. PubMed ID: 9752505
    [Abstract] [Full Text] [Related]

  • 35. Managing access to liver transplantation: implications for gastroenterology practice.
    Brown R, Emond JC.
    Gastroenterology; 2007 Mar; 132(3):1152-63. PubMed ID: 17383434
    [No Abstract] [Full Text] [Related]

  • 36. Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation.
    Vernadakis S, Poetsch M, Weber F, Treckmann J, Mathe Z, Baba HA, Paul A, Kaiser GM.
    Transpl Int; 2010 Mar 01; 23(3):341-3. PubMed ID: 19737373
    [No Abstract] [Full Text] [Related]

  • 37. [Principal indications for liver transplantation].
    Ichaï P.
    Rev Infirm; 2007 Dec 01; (136):22. PubMed ID: 18257489
    [No Abstract] [Full Text] [Related]

  • 38. [Increased incidence of hepatocellular carcinoma in western countries: the reasons and the consequences].
    Trinchet JC, Beaugrand M.
    Gastroenterol Clin Biol; 1999 Dec 01; 23(12):1286-8. PubMed ID: 10642616
    [No Abstract] [Full Text] [Related]

  • 39. [Therapeutic attitude in adult recipients waiting for liver transplantation].
    Hadengue A.
    Ann Radiol (Paris); 1994 Dec 01; 37(5):311-5. PubMed ID: 7993016
    [Abstract] [Full Text] [Related]

  • 40. [Indications for hepatic transplantation -- January 19 and 20, 2005, Lyon (Palais des congrès)].
    Haute Autorité de Santé.
    J Chir (Paris); 2005 Dec 01; 142(3):177-83. PubMed ID: 16142083
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.